Kunta JR - Search Results

1

Development, validation and utility of an in vitro technique for assessment of potential clinical drug-drug interactions involving P-glycoprotein.

Keogh JP, Kunta JR. Keogh JP, et al. Among authors: kunta jr. Eur J Pharm Sci. 2006 Apr;27(5):543-54. doi: 10.1016/j.ejps.2005.11.011. Epub 2006 Jan 10. Eur J Pharm Sci. 2006. PMID: 16406207

2

In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates.

Rautio J, Humphreys JE, Webster LO, Balakrishnan A, Keogh JP, Kunta JR, Serabjit-Singh CJ, Polli JW. Rautio J, et al. Among authors: kunta jr. Drug Metab Dispos. 2006 May;34(5):786-92. doi: 10.1124/dmd.105.008615. Epub 2006 Feb 2. Drug Metab Dispos. 2006. PMID: 16455806

3

Intestinal drug transporters: in vivo function and clinical importance.

Kunta JR, Sinko PJ. Kunta JR, et al. Curr Drug Metab. 2004 Feb;5(1):109-24. doi: 10.2174/1389200043489144. Curr Drug Metab. 2004. PMID: 14965254 Review.

4

Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model.

Dallas S, Salphati L, Gomez-Zepeda D, Wanek T, Chen L, Chu X, Kunta J, Mezler M, Menet MC, Chasseigneaux S, Declèves X, Langer O, Pierre E, DiLoreto K, Hoft C, Laplanche L, Pang J, Pereira T, Andonian C, Simic D, Rode A, Yabut J, Zhang X, Scheer N. Dallas S, et al. Mol Pharmacol. 2016 May;89(5):492-504. doi: 10.1124/mol.115.102079. Epub 2016 Feb 18. Mol Pharmacol. 2016. PMID: 26893303

5

Differentiation of gut and hepatic first-pass effect of drugs: 1. Studies of verapamil in ported dogs.

Lee YH, Perry BA, Lee HS, Kunta JR, Sutyak JP, Sinko PJ. Lee YH, et al. Among authors: kunta jr. Pharm Res. 2001 Dec;18(12):1721-8. doi: 10.1023/a:1013374630274. Pharm Res. 2001. PMID: 11785692

6

Active efflux kinetics of etoposide from rabbit small intestine and colon.

Kunta J, Yan J, Makhey VD, Sinko PJ. Kunta J, et al. Biopharm Drug Dispos. 2000 Apr;21(3):83-93. doi: 10.1002/1099-081x(200004)21:3<83::aid-bdd220>3.0.co;2-j. Biopharm Drug Dispos. 2000. PMID: 11113881

7

Differentiation of gut and hepatic first pass metabolism and secretion of saquinavir in ported rabbits.

Sinko PJ, Kunta JR, Usansky HH, Perry BA. Sinko PJ, et al. Among authors: kunta jr. J Pharmacol Exp Ther. 2004 Jul;310(1):359-66. doi: 10.1124/jpet.103.064394. Epub 2004 Mar 5. J Pharmacol Exp Ther. 2004. PMID: 15004217

8

Differentiation of gut and hepatic first-pass loss of verapamil in intestinal and vascular access-ported (IVAP) rabbits.

Kunta JR, Lee SH, Perry BA, Lee YH, Sinko PJ. Kunta JR, et al. Drug Metab Dispos. 2004 Nov;32(11):1293-8. doi: 10.1124/dmd.104.000752. Epub 2004 Aug 10. Drug Metab Dispos. 2004. PMID: 15304428

9

Development of a novel intestinal and vascular access port (IVAP) rabbit model to study regiospecific oral absorption pharmacokinetics.

Kunta JR, Perry BA, Sutyak JP, Sinko PJ. Kunta JR, et al. Comp Med. 2001 Aug;51(4):349-56. Comp Med. 2001. PMID: 11924794

10

Evaluation of organic anion transporting polypeptide 1B1 and 1B3 humanized mice as a translational model to study the pharmacokinetics of statins.

Salphati L, Chu X, Chen L, Prasad B, Dallas S, Evers R, Mamaril-Fishman D, Geier EG, Kehler J, Kunta J, Mezler M, Laplanche L, Pang J, Rode A, Soars MG, Unadkat JD, van Waterschoot RA, Yabut J, Schinkel AH, Scheer N. Salphati L, et al. Drug Metab Dispos. 2014 Aug;42(8):1301-13. doi: 10.1124/dmd.114.057976. Epub 2014 May 22. Drug Metab Dispos. 2014. PMID: 24855184

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page